All Products

Cat.No.

Product Name / Activity

Antibody recognizing NCAM

Antibody recognizing NK₁

Antibody recognizing N-Myc

Antibody recognizing rat NR1 subunits

Antibody recognizing rat NR1 subunits with alternative C' terminus

Antibody recognizing mouse NR2A subunits

Antibody recognizing rat NR3A subunits

Antibody recognizing mouse NR3B subunits

Antibody recognizing rat NR2A subunits phosphorylated at Ser¹²³²

Non-competitive NMDA receptor open-channel blocker

Endogenous CB₁ agonist. Also vanilloid agonist and inhibitor of FAAH and AMT

Highly potent, preferential D₃ antagonist

Serine protease inhibitor, inhibits tryptase

GnRH receptor agonist

α₁ antagonist

Selective µ₁ antagonist

Broad spectrum opioid antagonist

Full κ agonist, partial μ and δ agonist and antagonizes agonist-induced activation of NOP

Broad spectrum opioid antagonist

Standard δ₂ selective antagonist

δ selective non-peptide antagonist

Non-selective NOS inhibitor

5-HT_1A antagonist

Cyclooxygenase inhibitor

Selective r5-HT_1B antagonist. Active in vivo

Selective non-peptide CRF₁ antagonist

Equilibrative nucleoside transporter 1 (ENT1) inhibitor

Potent AMPA antagonist. More selective than CNQX (Cat. No. 0190)

Potent AMPA antagonist. More water soluble form of NBQX (Cat. No. 0373)

Antagonist of γ-hydroxybutyric acid

Selective σ₁ antagonist

Highly selective β₁-adrenoceptor antagonist

Adenosine receptor agonist

Novel inhibitor of non-apoptotic cell death (necroptosis)

5-HT_2A antagonist and 5-HT uptake inhibitor. Antidepressant

Cognitive enhancer

Potent HIV-1 protease inhibitor

Highly potent D₂-like antagonist. Also 5-HT_1A agonist

Endogenous tachykinin peptide

NK₂ agonist

Endogenous tachykinin peptide

Mammalian bombesin-like peptide

Mammalian bombesin-like peptide

Neurotensin-like peptide

Potent, endogenous NMU₁ and NMU₂ agonist

Endogenous modulator of blood pressure and flow, gut ion transport, feeding and body temperature

Implicated in pain modulation, opioid function and metabolism

Endogenous NPFF₁ and NPFF₂ agonist

Implicated in pain modulation and opioid function

NPFF₁ and NPFF₂ agonist

Endogenous NPBW1 and NPBW2 receptor agonist

Y₂ receptor agonist

Influences feeding and sexual behavior

Influences feeding and sexual behavior

Potent NPY Y₅ agonist; orexigenic

NPY Y₁ receptor agonist

NPY Y₁ receptor agonist

Endogenous neurotransmitter and endocrine modulator

Selective, competitive P2X antagonist

Potent P2X₃ antagonist

Selective P2Y₁₁/P2X₁ antagonist

Potent and selective P2X₁ antagonist

Highly selective P2X₁ antagonist

Selective non-transportable GlyT1 inhibitor

Potent and selective D₃ antagonist

CaM kinase III (eEF-2 kinase) inhibitor

α antagonist

K_ATP channel opener and NO donor

α4β2 agonist

Ca²⁺ channel blocker (L-type)

α₁ antagonist, L-type Ca²⁺ channel blocker. Less active enantiomer of Cat. No. 1123

α₁ antagonist, L-type Ca²⁺ channel blocker

Selective iNOS inhibitor

Androgen receptor antagonist. Orally active

Cyclooxygenase-2 (COX-2) inhibitor

Ca²⁺ channel blocker (L-type)

Non-selective NOS inhibitor. Sodium salt of (Cat. No. 0602)

Potent eNOS inhibitor

GABA uptake inhibitor

Noradrenalin re-uptake inhibitor

Ca²⁺ channel blocker (L-type)

Potent α_2C agonist

Muscarinic antagonist, M₁ > M₂

Non-selective NOS inhibitor

Selective NK₂ agonist

Water-soluble adenylyl cyclase activator

Selective NMDA agonist

Selection of 5 NMDA receptor (glycine site) ligands (Cat. Nos. 0219, 0281, 0742, 1493 and 0237)

Non-selective NOS inhibitor

NOS inhibitor (nNOS = eNOS >> iNOS)

GABA uptake inhibitor; moderately BGT-1 selective

Selective sst₄ agonist

Highly selective Ca²⁺ channel blocker (T-type)

Potent non-peptide NOP agonist; brain penetrant

Selective inhibitor of GAT-1

Endogenous NOP agonist

Potent ORL₁ agonist

Bioactive metabolite of nociceptin

Highly potent and selective NOP agonist

Potent, selective nociceptin receptor agonist

Selective, competitive nociceptin antagonist

Selective nociceptin agonist

Orphan neuropeptide

Opposes action of nociceptin

Human putative counterpart of nocistatin

Microtubule inhibitor

Competitive antagonist for Nogo-66 receptor; promotes neuron regeneration

Endogenous agonist for CB₁ and GPR55

Monovalent cation ionophore

Glucosidase inhibitor

Selective 5-HT_1B agonist

Potent, non-competitive NMDA antagonist

Tubulin inhibitor; induces apoptosis

Orally active AT₂ agonist

Increases intracellular Ca²⁺ levels

Selective protein kinase C inhibitor

Caged fluorescent pH indicator

Caged proton

Chloride channel blocker

Potent and selective 5-HT₆ antagonist

Potent and selective NPY Y₅ antagonist

Blocking peptide for anti-NR1, alternative CT (Cat. No. 2054)

hERG channel activator. Antiarrhythmic

Positive allosteric modulator of α7 nAChR; active in vivo

Selective non-competitive kainate antagonist; selective for GLU_K5

Cyclooxygenase (COX-2) inhibitor

Selective Chk2 inhibitor

Cell-permeable, genotype-selective antitumor agent; activates p53-dependent transcription

Selective inhibitor of Rac1-GEF interaction; antioncogenic

Histone deacetylase inhibitor

Cyclin-dependent kinase 4 (cdk4) inhibitor

Inhibitor of ubiquitin isopeptidase activity

Potent, selective Cdc25 phosphatase inhibitor

MDM2 inhibitor. Disrupts MDM2-p53 interaction

Cdk inhibitor. Also inhibits GSK-3

Potent inhibitor of shp2 and shp1 PTP

Selective Cdc25 dual specificity phosphatase inhibitor

Potent and selective non-peptidic Y₅ antagonist

p75^NTR fragment; induces apoptosis

Potent, selective PPARγ partial agonist

Potent PARP inhibitor

Cdk1 and cdk2 inhibitor

Selective DNA-dependent protein kinase inhibitor

Potent and selective DNA-dependent protein kinase inhibitor

Potent, orally active DPP-IV inhibitor

Inhibits actin assembly

Free radical trapping agent; neuroprotectant